Glucose-6-phosphate dehydrogenase at the crossroads of redox homeostasis and regulated cell death in erythrocytes
- 1Department of Medical Biochemistry, School of Medicine, Koç University
- 2Koç University Research Center for Translational Medicine (KUTTAM)
Abstract
Glucose-6-phosphate dehydrogenase (G6PD) provides the sole source of NADPH in mature erythrocytes, fueling the cell’s essential antioxidant defenses. Although G6PD deficiency is traditionally tied to acute oxidative hemolysis, red cell loss extends beyond simple membrane rupture. This perspective evaluates G6PD-dependent NADPH supply as a metabolic redox checkpoint that controls the balance between erythrocyte survival, regulated cell death, and clearance. Reduced NADPH availability can limit glutathione regeneration and thus decrease GPX4-dependent lipid peroxide detoxification. Although this biochemical relationship provides a possible link between redox imbalance and erythrocyte injury, the direct involvement of ferroptosis and necroptosis-like pathways in mature erythrocytes remains insufficiently proven. Acute hemolysis, in this view, is a downstream consequence of these regulated events rather than the primary cause. G6PD is essential for erythrocyte survival as their sole source of NADPH. G6PD deficiency alone does not always cause cell death, but under oxidative stress, it acts as a metabolic checkpoint that shifts red blood cells from survival to regulated death rather than simple osmotic lysis.
Related
- Sphingosine-1-phosphate ameliorates necrotizing enterocolitis by regulating mitochondrial redox homeostasis and gut microbiota.
- XPR1, key regulator of phosphate homeostasis and potential drug target for ovarian and lung cancer.
- Knob architecture and hemoglobin composition shape recovery dynamics of Plasmodium falciparum-infected erythrocytes
- TMAO at the Crossroads of the Gut–Brain Axis: Emerging Mechanisms Linking Microbiota-Derived Metabolites to Neuroinflammation and Cognitive Dysfunction
- PRMT7 at the crossroads of cancer progression and therapeutic targeting (Review).
BibTeX
@article{ulusu2026glucose6phosphate,
title = {{Glucose-6-phosphate dehydrogenase at the crossroads of redox homeostasis and regulated cell death in erythrocytes}},
author = {Nuriye Nuray Ulusu},
journal = {Frontiers in Pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1958205},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1958205/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Glucose-6-phosphate dehydrogenase at the crossroads of redox homeostasis and regulated cell death in erythrocytes
AU - Nuriye Nuray Ulusu
PY - 2026
DA - 2026/10/26
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1958205
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1958205/full
AB - Glucose-6-phosphate dehydrogenase (G6PD) provides the sole source of NADPH in mature erythrocytes, fueling the cell’s essential antioxidant defenses. Although G6PD deficiency is traditionally tied to acute oxidative hemolysis, red cell loss extends beyond simple membrane rupture. This perspective evaluates G6PD-dependent NADPH supply as a metabolic redox checkpoint that controls the balance between erythrocyte survival, regulated cell death, and clearance. Reduced NADPH availability can limit glutathione regeneration and thus decrease GPX4-dependent lipid peroxide detoxification. Although this biochemical relationship provides a possible link between redox imbalance and erythrocyte injury, the direct involvement of ferroptosis and necroptosis-like pathways in mature erythrocytes remains insufficiently proven. Acute hemolysis, in this view, is a downstream consequence of these regulated events rather than the primary cause. G6PD is essential for erythrocyte survival as their sole source of NADPH. G6PD deficiency alone does not always cause cell death, but under oxidative stress, it acts as a metabolic checkpoint that shifts red blood cells from survival to regulated death rather than simple osmotic lysis.
SN - 1663-9812
ER -